After Hours
$
0.96
Change
-0.02 -2.06%
Volume
Volume 6,457
Sep 22, 2023, 5:08 p.m.
Quotes are delayed by 20 min
Previous close
$ 0.98
$ 0.98
Change
+0.0002 +0.02%
Day low
Day high
$0.96
$1.02

52 week low
52 week high
$0.51
$1.49

Market cap
$86.58M
Average volume
312,518
P/E ratio
N/A
Rev. per Employee
$108,696
EPS
-0.39
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on CGEN
-
Compugen stock price target cut to $14 from $20 at Truist
- Tomi Kilgore
-
Why ARK Innovation Is a Different Fund Today Than It Was a Year Ago
- Barron's Online
-
These 2 stocks will profit from transformative tech trends
- Philip van Doorn
-
Compugen started at buy with $19 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
Compugen started at buy with $16 stock price target at SunTrust RH
- Tomi Kilgore
-
Compugen's stock soars 18% premarket after Bristol-Myers to take equity stake as part of collaboration
- Tomi Kilgore
-
Stocks close higher as technology shares rally
- Sue Chang
-
Compugen says FDA has removed clinical hold on immuno-oncology therapeutic antibody
- Ciara Linnane
-
Compugen shares surge 6% premarket
- Ciara Linnane
-
Compugen started at outperform with $14 stock price target at FBR & Co.
- Tomi Kilgore
-
Compugen to receive $1.2 mln milestone payment
- Ciara Linnane
-
Compugen achieved initial milestone in cancer trial with Bayer
- Ciara Linnane
- Loading more headlines...
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For March 29, 2018
- Benzinga.com
-
Oppenheimer Is Excited About These 3 Biotech Stocks
- Benzinga.com
-
- Benzinga.com
Other News on CGEN
-
Compugen Ltd. (CGEN) Q3 2022 Earnings Call Transcript
- Seeking Alpha
Press Releases on CGEN
-
Compugen Reports First Quarter 2023 Results
- PR Newswire - PRF
-
Compugen to Present at the JMP Securities Life Sciences Conference
- PR Newswire - PRF
-
Compugen to Release First Quarter 2023 Results on Monday, May 15, 2023
- PR Newswire - PRF
-
Compugen Reports Fourth Quarter and Full Year 2022 Results
- PR Newswire - PRF
-
Compugen to Present at the SVB Securities Global Biopharma Conference
- PR Newswire - PRF
-
Compugen to Participate in the JMP Securities Hematology and Oncology Summit
- PR Newswire - PRF
-
Compugen Reports Third Quarter 2022 Results
- PR Newswire - PRF
-
Compugen to Participate in the Stifel Healthcare Conference
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com